Vic and guest host Emily Evans discuss declining consumer sentiment, challenges in the labor market, and the growing impact of AI on jobs and small businesses. They examine FDA food regulation and the debate around "generally regarded as safe" ingredients, Medicaid policy changes and fraud enforcement efforts under CMS, the expansion of AI from large enterprises to Main Street businesses, concerns that GLP-1 weight loss drugs may contribute to muscle loss and frailty, and major developments in the AI infrastructure race, including Amazon's multibillion-dollar chip deal.
Links
Story 1: Economy
Story 2: VC rundown
Story 3: Political Hard-Ball Impacts Medicaid
Story 5: HHS Fraud Crackdown
Story 6: CVS and the end of PBMs
Story 7: Training more Docs (finally)
Story 8: Quorum as a Nonprofit
Story 9: Big Health Brands moving quickly
Story 10: Lilly’s moves
Story 11: GLP1 Side Effects
Story 12: Ebola Watch
Story 13: New Chip Entries Grow
Story 14: New Chip Entries Grow
Story 15: Huge Math Discovery
What is Health:Further?
Every week, healthcare VCs and Jumpstart Health Investors co-founders Vic Gatto and Marcus Whitney review and unpack the happenings in US Healthcare, finance, technology and policy. With a firm belief that our healthcare system is doomed without entrepreneurship, they work through the mud to find the jewels, highlight headwinds and tailwinds, and bring on the smartest guests to fill in the gaps.